GIM
CDTX

Granahan Investment Management’s Cidara Therapeutics CDTX Stock Holding History

Granahan Investment Management’s Portfolio CDTX Stock Details CDTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-2,504
Closed -$133K – 196
2021
Q1 		$133K Sell
2,504
-21,088
-89% -$1.04M ﹤0.01% 190
2020
Q4 		$944K Sell
23,592
-4,544
-16% -$226K 0.02% 185
2020
Q3 		$1.6M Buy
28,136
+225
+0.8% +$15.9K 0.05% 162
2020
Q2 		$2.06M Sell
27,911
-854
-3% -$55.3K 0.07% 153
2020
Q1 		$1.43M Buy
28,765
+5,259
+22% +$315K 0.08% 152
2019
Q4 		$1.8M Buy
23,506
+298
+1% +$13.6K 0.08% 144
2019
Q3 		$926K Buy
23,208
+1,342
+6% +$45.1K 0.05% 157
2019
Q2 		$735K Sell
21,866
-186
-0.8% -$7.73K 0.04% 169
2019
Q1 		$1.17M Sell
22,052
-1,534
-7% -$84.1K 0.06% 166
2018
Q4 		$1.11M Sell
23,586
-421
-2% -$30K 0.08% 162
2018
Q3 		$2.11M Buy
24,007
+1,207
+5% +$107K 0.11% 152
2018
Q2 		$2.37M Buy
+22,800
New +$2.15M 0.14% 153

Other funds holding CDTX

BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
5VM
5AM Venture Management San Francisco, California $288M AUM 313.93% 1-Year Est. Return
OFM
Omega Fund Management Boston, Massachusetts $186M AUM 155.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
IVM
InterWest Venture Management San Francisco, California $20.6M AUM 48.5% 1-Year Est. Return
SCM
Stonepine Capital Management Bend, Oregon $177M AUM 91.13% 1-Year Est. Return
ACM
Alethea Capital Management Mercer Island, Washington $241M AUM 112.74% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Jacobs Levy Equity Management
Jacobs Levy Equity Management Florham Park, New Jersey $27.8B AUM 46.46% 1-Year Est. Return

Granahan Investment Management's CDTX Position: Q2 2021 in Review

Granahan Investment Management sold out of Cidara Therapeutics (CDTX) in Q2 2021, closing a stake of 2,504 shares — an estimated $133K sold.

Granahan Investment Management first reported a position in CDTX in Q2 2018 and held it in 12 quarters. The position peaked at $2.37M in Q2 2018. 55 funds tracked by Wall St. Rank hold CDTX as of Q2 2021.

  • Granahan Investment Management reported no remaining Cidara Therapeutics position as of Q2 2021 after selling out during the quarter.
  • Granahan Investment Management sold 2,504 Cidara Therapeutics shares in Q2 2021, an estimated $133K.
  • Granahan Investment Management first reported a position in Cidara Therapeutics in Q2 2018 and held it in 12 quarters.
  • Granahan Investment Management's Cidara Therapeutics position peaked at $2.37M in Q2 2018.
  • 55 funds tracked by Wall St. Rank held Cidara Therapeutics as of Q2 2021.

Based on Granahan Investment Management's 13F filing for Q2 2021, filed 16 Aug 2021.